Refractory Infantyl Chylous Ascites Treatment by Everolimus

Area of Science:

• Pediatric Gastroenterology
• Clinical Medicine
• Medical Case Reports

Background:

• Chylous ascites is the accumulation of lymphatic fluid in the abdomen.
• Congenital anomalies are the primary cause in pediatric patients.
• Standard treatments include dietary management (high protein, low fat, medium-chain fatty acids), total parenteral nutrition, and somatostatin.

Purpose of the Study:

• To report a case of pediatric chylous ascites refractory to standard treatment.
• To evaluate the efficacy of everolimus in managing refractory chylous ascites in a pediatric patient.

Main Methods:

• A six-month-old female infant diagnosed with chylous ascites.
• Initial treatment with standard nutritional therapy and somatostatin.
• Administration of everolimus upon failure of standard therapies.

Main Results:

• The patient did not respond to conventional nutritional therapy and somatostatin.
• Everolimus treatment successfully controlled the chylous ascites.
• This suggests everolimus as a potential alternative therapy for refractory cases.

Conclusions:

• Standard treatments for pediatric chylous ascites may not always be effective.
• Everolimus demonstrated efficacy in managing a refractory case of pediatric chylous ascites.
• Further research into novel agents like everolimus for chylous ascites is warranted.